Demeclocycline
| Clinical data | |
|---|---|
| Trade names | Declomycin |
| Other names | RP-10192, demethylchlortetracycline |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682103 |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 60–80% |
| Protein binding | 41–50% |
| Metabolism | Hepatic |
| Elimination half-life | 10–17 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.004.396 |
| Chemical and physical data | |
| Formula | C21H21ClN2O8 |
| Molar mass | 464.86 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Demeclocycline (INN, BAN, USAN, brand name Declomycin) is a tetracycline antibiotic which was derived from a mutant strain of Streptomyces aureofaciens.